We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+7.18%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$39.5B
AUM Growth
+$2.7B
Cap. Flow
+$445M
Cap. Flow %
1.13%
Top 10 Hldgs %
32.24%
Holding
1,130
New
120
Increased
244
Reduced
465
Closed
118

Sector Composition

Rank Sector Weight
1 Technology 20%
2 Consumer Discretionary 13.07%
3 Healthcare 12.03%
4 Financials 11.81%
5 Communication Services 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMC
351
DELISTED
PharMerica Corporation
PMC
$13.6M 0.03%
486,120
-13,688
-3% -$351K
MJN
352
DELISTED
Mead Johnson Nutrition Company
MJN
$13.6M 0.03%
172,488
-18,712
-10% -$1.6M
GCP
353
DELISTED
GCP Applied Technologies Inc.
GCP
$13.6M 0.03%
480,722
-106,925
-18% -$2.97M
SF
354
Stifel
SF
$12.6B
$13.6M 0.03%
796,066
-22,434
-3% -$360K
CHK
355
DELISTED
Chesapeake Energy Corporation
CHK
$13.5M 0.03%
10,793
-275
-2% -$317K
ODFL icon
356
Old Dominion Freight Line
ODFL
$44.9B
$13.5M 0.03%
589,536
-16,962
-3% -$383K
IBP icon
357
Installed Building Products
IBP
$6.49B
$13.4M 0.03%
+374,954
New +$13M
AIN icon
358
Albany International
AIN
$1.78B
$13.3M 0.03%
314,499
-8,878
-3% -$373K
RAVN
359
DELISTED
Raven Industries Inc
RAVN
$13.3M 0.03%
575,698
-16,564
-3% -$357K
FNFV
360
DELISTED
Fidelity Natl Financial, Inc.
FNFV
$13.2M 0.03%
1,061,082
-29,990
-3% -$369K
MDCO
361
DELISTED
Medicines Co
MDCO
$13.1M 0.03%
346,546
+346,486
+577,477% +$13.1M
AVNS
362
DELISTED
Avanos Medical
AVNS
$13.1M 0.03%
377,130
-10,948
-3% -$383K
KAI icon
363
Kadant
KAI
$3.99B
$13.1M 0.03%
250,634
-55,213
-18% -$2.95M
ROG icon
364
Rogers Corp
ROG
$2.4B
$13.1M 0.03%
213,797
-15,749
-7% -$956K
FFIN icon
365
First Financial Bankshares
FFIN
$4.97B
$13M 0.03%
714,118
-213,114
-23% -$3.75M
WLY icon
366
John Wiley & Sons Class A
WLY
$2.66B
$12.9M 0.03%
249,637
-6,955
-3% -$381K
TCBI icon
367
Texas Capital Bancshares
TCBI
$4.32B
$12.8M 0.03%
232,354
-6,413
-3% -$323K
SRCI
368
DELISTED
SRC Energy Inc
SRCI
$12.7M 0.03%
1,839,638
-51,803
-3% -$342K
W icon
369
Wayfair
W
$14.6B
$12.6M 0.03%
319,088
-14,515
-4% -$587K
LAMR icon
370
Lamar Advertising Co
LAMR
$16.3B
$12.6M 0.03%
192,291
+192,152
+138,239% +$12.4M
CBT icon
371
Cabot Corp
CBT
$4.52B
$12.4M 0.03%
237,247
-6,238
-3% -$309K
EOG icon
372
EOG Resources
EOG
$70.7B
$12.4M 0.03%
128,473
+1,112
+0.9% +$97.6K
DOOR
373
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$12.4M 0.03%
199,529
-5,790
-3% -$388K
SRE icon
374
Sempra
SRE
$54.8B
$12.4M 0.03%
231,246
-23,156
-9% -$1.26M
VSTO
375
DELISTED
Vista Outdoor Inc.
VSTO
$12.4M 0.03%
309,913
-655,099
-68% -$28.9M

Similar funds

Loomis, Sayles & Company's Q3 2016 Portfolio in Review

As of Q3 2016, Loomis, Sayles & Company held 1,130 positions worth $39.5B, up 7.3% from $36.8B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Loomis, Sayles & Company's Q3 2016 filing shows 120 new, 244 increased, 465 reduced and 118 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,148,117 shares worth $462M. The largest sale was ARM HOLDINGS PLC ADS, an estimated $471M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Loomis, Sayles & Company's largest Q3 2016 buy was Regeneron Pharmaceuticals: 1,148,117 shares worth $462M.
  • Loomis, Sayles & Company added most to Deere & Co in Q3 2016, an estimated $389M increase.
  • Loomis, Sayles & Company's biggest Q3 2016 reduction was Telefonica, cutting an estimated $67.4M.
  • Loomis, Sayles & Company fully exited ARM HOLDINGS PLC ADS in Q3 2016, selling an estimated $471M.
  • Loomis, Sayles & Company's ten largest holdings make up 32% of its $39.5B portfolio in Q3 2016.
  • Loomis, Sayles & Company opened 120 new positions and closed 118 in Q3 2016.
  • Loomis, Sayles & Company's portfolio value rose 7.3% quarter-over-quarter to $39.5B.

Based on Loomis, Sayles & Company's 13F filing for Q3 2016, filed 14 Nov 2016.